- Report
- October 2024
- 195 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 192 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- July 2024
- 599 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- April 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 140 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2023
- 111 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- July 2024
- 125 Pages
From €3293EUR$3,450USD£2,759GBP
- Report
- August 2024
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The qPCR Reagent market is a subset of the biotechnology industry, focusing on the production and sale of reagents used in quantitative polymerase chain reaction (qPCR) tests. qPCR is a laboratory technique used to detect and quantify the presence of specific DNA or RNA sequences in a sample. qPCR reagents are used to amplify and detect these sequences, and are essential for the accurate and reliable performance of qPCR tests.
The qPCR Reagent market is highly competitive, with a range of companies offering products for different applications. Companies in the market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, Promega Corporation, Takara Bio, and QIAGEN. Show Less Read more
